11.18.24 -- Is Executive Leadership At Today's CDMOs Up To The Job?

Sponsor and CDMO relationships are fertile ground for conflict. A measured approach can mitigate disruptions with troublesome contractors and high performers alike.

Liposome technology is an effective drug delivery tool but still presents difficulties. Learn how developers are meeting these challenges and the opportunities for advancement to maximize liposome usefulness.

Access to technical, process, and regulatory experts under one CDMO roof minimizes logistical and cost-related concerns for biopharmaceutical companies while offering improved control over production.

Explore study findings aiming to assist process development scientists and engineers in understanding the structure of depth filter capsules, identifying key parameters for development, and more.

This poster reviews studies for three monoclonal antibody drug candidates utilizing a panel of small-scale, fast, and predictive tests used to evaluate therapeutic antibodies’ developability.

Characterizing Fab and Fc-Fusion proteins and developing robust manufacturing processes can help usher them to market and provide new treatment options for diseases that are challenging to treat.

See how this process development platform for MVA is impacting vaccine manufacturing and supporting the drug lifecycle from process and analytical development through clinical trials and commercialization.

Learn how to navigate decision-making at critical steps and find solutions to key challenges in process development and scale-up to expedite oncolytic virus programs.

Explore the process of how a new fill line was planned for and implemented, while also considering how best to mitigate contamination risks.

Advances in sustained-release drug delivery could improve efficiency and consistency in drug release, manifesting real-life advantages for patients in the form of enhanced accessibility and compliance.

A scalable manufacture promises increased process understanding and manufacturing flexibility to deliver a robust, reliable commercial product, and it helps with timely delivery to market.

Strategically optimize your upstream and downstream processes and decrease the timeline from optimization to commercial manufacturing.

Delve into the details of this straightforward approach to maximize yields early in development, leveraging vaccine expertise, robust platforms, and Vero and Quail cell lines.

Gain insights into boosting efficiency, fostering innovation, and how integrated capabilities generate value for innovators.

Following the latest regulatory guidance, explore a range of methods designed for the fast and sensitive detection of adventitious agents in bulk harvest material.

We specialize in the production of sterile biotechnological products in a manufacturing plant that meets the requirements of GMP.

The therapeutic promise of biologicals has fundamentally changed health care. Samsung Biologics is committed to helping drug developers bring these promising new therapeutics to patients.

Consider our strong process development capabilities in both microbial and mammalian systems used to provide clients with process development, process optimization, and process troubleshooting.